Get started
Author

Chunxin Qin

Observed names: Chun-Xin Qin, Chun-xin Qin, Chun‑Xin Qin
ORCID: 0000-0001-7185-7421
Observed ORCID: 0000-0001-7185-7421
OpenAlex ID: A5049099741
Diagnosis of thyroid cancer using deep convolutional neural network models applied to sonographic images: a retrospective, multicohort, diagnostic study
2018 · Xiangchun Li, Sheng Zhang, et al. · The Lancet Oncology · 442
Deep learning to diagnose Hashimoto’s thyroiditis from sonographic images
2022 · Qiang Zhang, Sheng Zhang, et al. · Nature Communications · 59
PDF
Serum Dickkopf-1 expression level positively correlates with a poor prognosis in breast cancer
2014 · Shao-jie Zhou, Shou-rong Zhuo, et al. · Diagnostic Pathology · 43
PDF
Expression of NAMPT is associated with breast invasive ductal carcinoma development and prognosis
2018 · Shao‑Jie Zhou, Tie‑Qiang Bi, et al. · Oncology Letters · 39
PDF
Improved diagnosis of thyroid cancer aided with deep learning applied to sonographic text reports: a retrospective, multi-cohort, diagnostic study
2021 · Qiang Zhang, Sheng Zhang, et al. · Cancer Biology and Medicine · 13
PDF
MCM3AP-AS1 regulates proliferation, apoptosis, migration, and invasion of breast cancer cells via binding with ZFP36
2021 · Tian-Ping Tang, Chun-Xin Qin, et al. · Translational Cancer Research · 12
PDF
Granulomatous mastitis in multiparae during pregnancy and lactation
2021 · Song-tao Ding, Ya-jun Gao, et al. · Medicine · 10
High Expression of Asparagine Synthetase Is Associated with Poor Prognosis of Breast Cancer in Chinese Population
2020 · Chunxin Qin, Xiaoqing Yang, et al. · Cancer Biotherapy and Radiopharmaceuticals · 10
Connection between SOX7 Expression and Breast Cancer Prognosis
2020 · Chun-xin Qin, Xiao-qing Yang, et al. · Medical Science Monitor · 5
Development of a Risk Predictive Model for Evaluating Immune Infiltration Status in Invasive Thyroid Carcinoma
2022 · Runming Pang, Chunxin Qin · Evidence-based Complementary and Alternative Medicine · 3
PDF
Abstract P5-09-28: A phase I, prospective exploratory clinical study of neoadjuvant pyrotinib plus trastuzumab, dalpiciclib, and letrozole for patients with HR-positive, HER2-positive early or locally advanced breast cancer
2025 · Guangdong Qiao, Jun Lin, et al. · Clinical Cancer Research
Differences in risk factors for mortality between T2N1M0 and T3N0M0 lobular breast cancer patients: a comparative study
2025 · Longjie Xia, Chunxin Qin, et al. · Frontiers in Pharmacology
Works count: 12
Citation count: 636
H-index: 8
I10-index: 8
Year
Topic
Type